Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2025-12-24 @ 11:04 PM
NCT ID:
NCT03303469
Eligibility Criteria:
Inclusion Criteria:
* Adult (\> 18 years of age) patients with documented HCC tumor mass \>3cm, who are scheduled to undergo TACE with additional selective internal radiation therapy (SIRT)
* The appropriate criteria for inclusion for this patient population are:
* Biopsy or radiological diagnosis of HCC (defined as Organ Procurement and Transplantation Network (OPTN\*) Category 5 lesion either on CT or MRI)
* Scheduled for TACE (using doxorubicin-eluting beads) + SBRT
* Willingness to undergo PET/CT
* Able to lie on the imaging table for up to 1 hour.
* Able to provide signed informed consent.
* Women with childbearing potential must have a negative urine Beta-Human Chorionic Gonadotropin (β-hCG) test day of procedure
Exclusion Criteria:
* Estimated life expectancy \<12 months or serious medical co-morbidities that would preclude definitive local therapy
* Unable to lie on the imaging table
* Age less than 18 years.
* Pregnancy or lactation
* Inability or unwillingness to provide informed consent.
* Weight \>500 lbs (the weight limit of the tomograph gantry table)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03303469
Study Brief:
Protocol Section:
NCT03303469